5:33 PM
 | 
Dec 21, 2012
 |  BC Extra  |  Financial News

Alchemia falls on listing delays for U.S. subsidiary

Alchemia Ltd. (ASX:ACL) fell A$0.15 (28%) to A$0.40 on Friday after the company delayed plans to spin out its U.S. subsidiary Audeo Oncology Inc. (San Francisco, Calif.) and list it on U.S. and Australian exchanges....

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >